Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
11/1999
11/18/1999WO1999058149A1 Controlled activation of targeted radionuclides
11/18/1999WO1999058139A2 Methods for detecting and inhibiting angiogenesis
11/18/1999WO1999049931A3 Bismuth-213 generator and uses thereof
11/18/1999DE19818843A1 Radio-immuno conjugate comprising an antibody and a radioactive component with short half-life and limited radiation radius, useful for treating of hepatitis C virus infections
11/18/1999CA2328414A1 Methods for detecting and inhibiting angiogenesis
11/18/1999CA2324555A1 Pharmaceuticals for the imaging of angiogenic disorders
11/17/1999EP0956053A1 Method for treating neoplasia using humanized antibodies which bind to antigen a33
11/17/1999EP0956040A1 Stimulation of host defense mechanisms against viral challenges
11/17/1999EP0955885A1 Ventilation imaging using a fine particle aerosol generator
11/17/1999EP0697884B1 Ligand precursors for incorporation into peptides
11/16/1999US5986090 Metallized porphyrins
11/16/1999US5986074 Chelate compounds as imaging agents and kits
11/16/1999US5985941 Blends, homogenizing to form emulsions
11/16/1999US5985826 Methods of using hepatic-directed compounds in pretargeting strategies
11/16/1999US5985280 Diagnosis and/or therapy of tumours using monoclonal antibodies specific for the human IL-4 receptor
11/16/1999US5985241 Diagnostic and radiodiagnostic agents, formed by reacting technetium-99m with a somatostatin receptor-binding peptide
11/16/1999US5985240 Labeling somatostatin-derived peptides with perrhenate, treating rheumatoid arthritis,
11/11/1999WO1999057151A2 FAP α-SPECIFIC ANTIBODY WITH IMPROVED PRODUCIBILITY
11/11/1999WO1999056792A1 Positron emission tomography using gallium-68 chelates
11/11/1999WO1999056791A1 S3n radionuclide complexes
11/11/1999WO1999056790A2 13c glucose breath test for the diagnosis of diabetes
11/11/1999WO1999056789A1 Selection of contrast agent drug from a combinatorial library
11/10/1999EP0955066A2 Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents
11/10/1999EP0955044A2 Method of inhibiting bacterial or fungal growth using a complexing agent
11/10/1999EP0954340A1 Targeted combination immunotherapy of cancer
11/10/1999EP0584256B1 Compounds and pharmaceutical compositions for detecting and localizing tissues having neurokinine 1 receptors
11/10/1999CN1234742A Improvements in or relating to diagnostic/therapeutic agents and improvement relating to same
11/09/1999US5981725 Structural alterations of the EGF receptor gene in human tumors
11/09/1999US5981504 Genetic induction of receptors for targeted radiotherapy
11/09/1999US5981477 Peptide-metal chelate conjugates
11/09/1999US5981194 Determining or monitoring alzheimer's disease in patients suspected of having alzheimer's disease; measuring the concentration of protein marker in sample and compare it a control; monitoring therapies for alzheimer's disease
11/09/1999US5980896 Antibodies reactive with human carcinomas
11/09/1999US5980864 1,4,7,10-tetraazacyclododecane butyltriols, processes for their production and pharmaceutical agents containing them
11/09/1999US5980861 Chelator compositions and methods of synthesis thereof
11/09/1999US5980860 Dopamine and serotonin transporter ligands and imaging agents
11/04/1999WO1999056117A1 Radiation handling system and set
11/04/1999WO1999055387A1 Methods for detecting lesions in dense breast tissue using lhrh antagonists
11/04/1999WO1999055386A2 Stimulus sensitive gel with radioisotope and methods of making
11/04/1999WO1999055385A2 Radioimmunopharmaca for treating hepatitis c
11/04/1999WO1999055355A1 Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors
11/04/1999WO1999055285A2 Dilating and support apparatus with disease inhibitors and methods for use
11/04/1999WO1999040882A3 STEREOSELECTIVE Tc-99m LIGANDS
11/04/1999CA2329929A1 Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors
11/04/1999CA2329778A1 Improvements in or relating to diagnostic/therapeutic agents
11/04/1999CA2329352A1 Methods for detecting lesions in dense breast tissue using lhrh antagonists
11/03/1999EP0953639A1 FAPalpha-specific antibody with improved producibility
11/03/1999EP0953360A1 Technetium-99m radiolabelled diethylene triamine pentaacetic acid diester and process for the preparation of technetium-99m diethylene triamine penta-acetic acid diester
11/03/1999EP0953153A1 Novel method of diagnosing and treating gliomas
11/03/1999EP0952853A2 Conjugate comprising an active agent, a polypeptide and a polyether
11/03/1999CN1234072A Anti-ErbB2 antibodies
11/03/1999CN1046095C Medicine for treating rheumatoid disease
11/02/1999US5977323 Purifying inflammatory cytokine/chemokine by immunoaffinity chromatography; complexing chemokine to anti-gro antibodies bound to matrix, eluting chemokine
11/02/1999US5977307 Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins
11/02/1999US5977163 Water soluble paclitaxel prodrugs
11/02/1999US5977107 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists
11/02/1999US5977064 Cyclic tetrapeptide as anticoagulant
11/02/1999US5976535 Pretargeting protocols for the enhanced localization of cytotoxins to target sites and cytotoxic combinations useful therefore
11/02/1999US5976498 Methods of diagnostic image analysis using metal complexes of nitrogen-containing macrocyclic ligands
11/02/1999US5976497 3-(4-(2-pyridinyl))piperazinylmethyl)pyrrolo(2.3-b)pyridine and derivatives
11/02/1999US5976496 Labeled somatostatin analogs for imaging cardiovascular disease
11/02/1999US5976495 Peptide derived radionuclide chelators
11/02/1999US5976494 Technetium-99m labeled peptides for imaging
11/02/1999US5976493 Metabolically cleavable dendrimeric polychelants
11/02/1999US5976492 Radioactive phosphorus labeled proteins for targeted radiotherapy
10/1999
10/28/1999WO1999054954A2 Cd4 radio-immunological pharmaceuticals for the treatment of hiv infections
10/28/1999WO1999038866A8 8-azabicyclo[3.2.1]oct-2-ene derivatives in labelled form and use of 8-azabicyclo[3.2.1]oct-2-ene derivatives in labelled and unlabelled form
10/27/1999EP0951478A1 Polysaccharide-peptide derivatives
10/27/1999CN1233289A TNF-Beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods
10/27/1999CN1232866A Gallnut oil and its extraction process and application in pharmacy
10/26/1999US5972956 Inhibiting amyloid aggregation in a mammal by administering a 1-(mono or di substituted, or cyclized amino-alkyl-amino), 4-nitro,5-(hydrogen or alkyl), acridine compounds; useful in treating alzheimer's disease
10/26/1999US5972890 Polypeptide with label; diagnosis
10/26/1999US5972622 Method of detecting apoptosis using an anti-human GP46 monoclonal anti-body
10/26/1999US5972338 ?tie? or ?tie? are acronyms, which stand for ?tyrosine kinase containing ig and egf homology domains?; present invention concerns novel human tie ligand homologues with powerful effects on vasculature; antitumor agents
10/26/1999US5972337 46 kilodalton human milk fat globule (HMFG) antigen, fragments and fusion protein
10/26/1999US5972308 Reacting technetium-99 with a cyclic oligopeptide having amino acid units containing a mercaptan group attached to the ring through a homocysteine unit.
10/21/1999WO1999052861A1 Novel benzyl guanidine derivatives for therapy and in-vivo and in-vitro diagnosis
10/21/1999WO1999052565A1 Radionuclide excited phosphorescent material for administering pdt
10/21/1999WO1999052505A1 Use of particulate contrast agents in diagnostic imaging for studying physiological parameters
10/21/1999WO1999039746A3 Radioactive seed implants
10/21/1999WO1999036105A9 USE OF RADIOLABELED MONOCLONAL IgM IN THERAPY FOR CANCER AND AUTOIMMUNE DISEASE
10/21/1999DE19916896A1 Particles for chelating metal ions, useful in cosmetic, pharmaceutical and food products and products for treating liquids, especially water
10/21/1999CA2327816A1 Use of particulate contrast agents in diagnostic imaging for studying physiological parameters
10/20/1999EP0950105A1 Tnf-beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods
10/20/1999EP0949920A1 Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
10/20/1999CN1232501A Modified TIE-2 -receptor ligands
10/20/1999CN1045772C Polyazacycloalkanes as dichelants
10/19/1999US5969111 Radiation sensistizers
10/19/1999US5969110 Antibodies which are immunoreactive with a human tyrosine kinase ligand protein
10/19/1999US5968512 Antibody recognizing endothelial cell ligand for leukocyte CR3
10/19/1999US5968477 Radiolabeled annexin conjugates with hexose and a chelator
10/19/1999US5968476 Technetium-99m labeled peptides for thrombus imaging
10/14/1999WO1999051628A1 Radiopharmaceuticals for imaging infection and inflammation and for imaging and treatment of cancer
10/14/1999WO1999051594A1 IMIDAZO[1,2-a]PYRIDINES AS PERIPHERAL BENZODIAZEPINE RECEPTOR BINDING AGENTS
10/14/1999WO1999051299A2 Radioactive composition for fabrication of implanted device
10/14/1999WO1999051278A1 Inorganic material for radioactive drug delivery
10/14/1999WO1999051277A1 Enhancement of cellular gallium uptake
10/14/1999WO1999051276A1 Tin-free rhenium(v) complexes and methods for their preparation
10/14/1999DE19817517A1 New benzylguanidine derivatives useful for diagnosis or therapy, especially of neuroblastoma
10/14/1999CA2326978A1 Radiopharmaceuticals for imaging infection and inflammation and for imaging and treatment of cancer
10/14/1999CA2326977A1 Inorganic material for radioactive drug delivery
1 ... 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 ... 243